Raul Mitrani, M.D.
- Fax: 305-243-5565
- Cardiovascular Disease - Internal Medicine
- Clinical Cardiac Electrophysiology-Internal Medicine
- Internal Medicine
- American Board of Internal Medicine
- American Board of Internal Med-Cardiovascular Disease
- American Board of Int Med-Clinical Cardiac Electrophysiology
- Associate Professor
- Director, Cardiac Electrophysiology Fellowship Training Program
- Director, Clinical Cardiac Electrophysiology
- Director, University of Miami Hospital Cardiac Electrophysiology Laboratory
1. Effect of cardiac stem cells on Cardiac Arrhythmias
2. Optimizing Therapy for patients with Atrial Fibrillation
3. Disparities of Care in Patients with implantable defibrillators or in patients receiving catheter ablation
- MITRANI RD, Sager SJ, Moscucci M, Cogan J, Myerburg RJ. Transient Variations of Transthoracic Impedance as a Predictor of Heart Failure and Death in Patients with Implanted Defibrillators. Int J Cardiol 2014, 175:473-7.
- Badheka AO, Patel NJ, Grover P, Shah N, Patel N, Singh V, Deshmukh AJ, Mehta K, Chothani A, Savani GT, Arora S, Rathod A, Marzouka G, Lafferty J, Mehta J, MITRANI RD. Optimal Blood Pressure in Patients with Atrial Fibrillation. Am J Cardiol 2014, 114: 727-736.
- Patel NJ, Hoosien M, Beshmukh A, Badheka AO, Grover PM, Shah N, Signh V, Mehta K, Chothani A, Savani GT, Arora S, Bhalara V, Patel N, Khalpada D, Rathod A, Vazzana TJ, Lafferty J, Viles-Gonzalez JF, MITRANI RD. Digoxin signifanctly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function. Int J Cardiol 2013
- Badheka AO, Marzouka GR, Rathod A, Patel N, Myerburg RJ, MITRANI RD. Comparison of Rate vs Rhythm Control in Patients with Atrial Fibrillation and a Pacemaker. Am J Cardiol 2013; 111:1759-63.
- MITRANI RD, Mcardle A, Slane M, Cogan J, Myerburg RJ. Wearable Defibrillators in Uninsured Patients with Newly-Diagnosed Cardiomyopathy or Recent Revascularization in a Community Medical Center. Amer Heart J 2013; 165:386-92
Case Western Reserve University
Case Western Reserve University
Columbia University, College of Physicians & Surgeons
Dr Raul Mitrani is Director of Clinical Cardiac Electrophysiology at University of Miami, Miller School of Medicine and has been treating patients with heart rhythm disorders for over 20 years. As an Academic Cardiac Electrophysiologist, Dr Mitrani treats patients with simple and complex cardiac arrhythmias including atrial fibrillation, ventricular tachycardia, supraventricular tachycardia and syncope. Dr Mitrani performs invasive and non-invasive diagnostic tests to help guide therapy. He has performed numerous catheter ablations over his career using the most advanced techniques to ablate the sources of cardiac arrhythmias by delivering radiofrequency or cryoballoon energy. In addition, Dr Mitrani implants cardiac pacemakers, defibrillators and diagnostic monitors in patients needing these devices
In addition to his clinical responsibilities, Dr Mitrani is actively involved in research and teaching. He has authored or coauthored numerous papers on diverse topics including the role of cardiac stem cells in cardiac arrhythmias, optimal blood pressure control in patients with atrial fibrillation, and others. He participates in NIH sponsored multicenter trials such as the CABANA Trial, a study to compare catheter ablation versus pharmacologic therapy in patients with atrial fibrillation. Lastly, he actively participates in teaching from medical students to Cardiac Electrophysiology Fellows and won the 2012 Cardiology Teaching Award.